4Zile MR, Brutsaert DL New concepts in diastolic dysfunction and dias- tolic heart failure : Part 1 diagnosis, prognosis, and measurements of dias- tolic function[J] Circulation ,2002 ; 105 ( 1 ) : 1387-93.
5Hogg K,Swedberg K,McMurray J. Heart failure with preserved left ven- tricular saystolic function, epidemiology, clinical characteristics and prog- nosis[J]. J Am Coll Cardio1,2004 ;43 (3) :317-27.
6Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventrieular ejection fraction by the heart failure and echocar- diography associations of the european society of cardiology[J] Eur Heart J,2007 ;28(20) :2539-50.
5He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation ,2004,110:405-411.
6Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults ( adult treatment panel Ⅲ ) JAMA,2001,285:2486-2497.
7Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease iisk factor clustering among the adult population of China: results from the international collaborative study of cardiovascular disease in Asia (InterAsia). Circulation, 2005,112:658-665.
9Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation, 2002,105:1387-1393.
10European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J, 1998, 19:990-1003.
4Chen Y,Wu Z, Yang C, et al. Investigation of atrial vulnerabili- ty by analysis of the sinus node EG from atrial fibrillation mod- els using a phase synchronization method[J]. IEEE Transac- tions on Biomedical Engineering,2012,59(9):2668-2676.
5Gurrapu A, Jukanti R, Bobbala SR,et al. Improved oral deliv- ery of valsartan from maltodextrin based proniosome powders[J]. Advanced Powder Technology,2012,23(5) :583-590.
